Johns Hopkins ABX Guide
Sulfisoxazole
INDICATIONS
FDA
FDA
- Urinary tract infection (pyelonephritis and cystitis)
- Nocardia
- Plasmodium falciparum, resistant to chloroquine.
- Toxoplasmosis in combination with pyrimethamine (sulfadiazine preferred)
- Otitis media (pediatric) in combination with PCN also trachoma including inclusion conjunctivitis, chancroid, meningococcal meningitis prophylaxis when sulfonamide-sensitive group A strains are known to prevail and meningitis caused by H. influenzae in combination with streptomycin (pediatric suspension)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 20, 2019
Citation
Dzintars, Kathryn, and Paul A Pham. "Sulfisoxazole." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540530/5.1/Sulfisoxazole.
Dzintars K, Pham PA. Sulfisoxazole. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540530/5.1/Sulfisoxazole. Accessed December 27, 2024.
Dzintars, K., & Pham, P. A. (2019). Sulfisoxazole. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540530/5.1/Sulfisoxazole
Dzintars K, Pham PA. Sulfisoxazole [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 27]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540530/5.1/Sulfisoxazole.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sulfisoxazole
ID - 540530
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2019/02/20/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540530/5.1/Sulfisoxazole
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
